The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
 
 
 
 

One year efficacy and tolerability of oxprenolol slow-release and chlorthalidone on fixed combination in mild to moderate hypertension.

The long-term antihypertensive efficacy and tolerability of a fixed combination of oxprenolol 160 mg slow-release + chlortalidone 20 mg was studied in 40 out-patients with mild to moderate essential hypertension followed during one year with monthly clinical visits. The fixed combination was given at the dosage of 1 tablet once daily, in the morning, increasing to 1 tablet b.i.d. in case of lying diastolic blood pressure greater than 95 mmHg. After one year only 9 patients were on 1 tablet b.i.d., the others remaining on 1 tablet once daily regimen. Clear-cut antihypertensive effect was already evident after the 1st month of treatment. Both systolic and diastolic blood pressure further decreased after two months (p less than 0.01) showing then a constant trend to decrease till the 6th month; afterwards blood pressure values remained unchanged. Normalization of blood pressure was obtained in 63%, 73% and 80% of the patients, respectively after 1, 6 and 12 months of treatment. Laboratory data did not show significant changes. Only 3 patients complained of unwanted effects which were mild, transient and in no case compelled to interrupt the treatment. Results confirm that the fixed combination of oxprenolol 160 mg slow-release + chlorthalidone 20 mg is able to long term control mild to moderate hypertension with a good tolerability, thus allowing an improved patient compliance.[1]

References

  1. One year efficacy and tolerability of oxprenolol slow-release and chlorthalidone on fixed combination in mild to moderate hypertension. Masoni, A., Tomasi, A.M., Pirani, R., Lazzaretto, R., Ambroso, G. Giornale italiano di cardiologia. (1981) [Pubmed]
 
WikiGenes - Universities